Cancer immunology is the study of how the immune system interacts with cancer, including how it recognizes and responds to tumour cells and how cancers evade or suppress immune defences. It provides the scientific foundation for immunotherapy, a class of treatments that harness or enhance the immune system to fight …
Cancer immunology is the study of how the immune system interacts with cancer, including how it recognizes and responds to tumour cells and how cancers evade or suppress immune defences. It provides the scientific foundation for immunotherapy, a class of treatments that harness or enhance the immune system to fight cancer. The field examines the immune cells and molecules involved in detecting abnormal cells, the mechanisms tumours use to escape immune surveillance, and the biomarkers that indicate immune responses to disease and treatment. Research relevant to hematology and oncology engages with these questions, including work on current immunoassays and emerging immunogenomic approaches for immunomonitoring cancer and infectious diseases, which addresses the tools used to measure and characterize immune activity in patients. Such methods support the assessment of how the immune system responds to tumours and to therapy. As a topic, cancer immunology connects to broader study of tumour biology, immune regulation, immunodiagnostics, and the development of immunotherapeutic strategies. This page gathers peer-reviewed, open-access research relevant to cancer immunology and to the wider study of hematology and oncology.
2 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The 2 articles above have been cited 41 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
A sample of recent works citing this journal's research on Cancer Immunology, linking to each citing work.